HealthQuill Central Nervous System
AbbVie Inc. will acquire Aliada Therapeutics, a biotechnology company focused on developing drugs to treat diseases of the central nervous system such as Alzheimer’s disease, for $1.4 billion in cash.
Drugs Health Pharma

AbbVie to acquire Aliada for $1.4 billion, bags Alzheimer’s therapy 

AbbVie Inc. will acquire Aliada Therapeutics, a biotechnology company focused on developing drugs to treat diseases of the central nervous system such as.

Read More
Eating tuna may expose humans to methylmercury, a toxic chemical compound that affects the central nervous system, according to a study.
Climate Health Pharma

Toxic mercury levels remain stagnant in tuna for last 53 years: Study

HQ Team February 22, 2024: Eating tuna may expose humans to methylmercury, a toxic chemical that affects the central nervous system, and the.

Read More
The US’s medical research agency has discovered more than 3,000 new types of brain cells in different clusters of the organ that may help in the treatment of cancer and neurodegenerative diseases.
Drugs Health Pharma

NIH researchers find 3,000 new brain cells, create ‘most detailed’ atlas

HQ Team November 1, 2023: The US’s medical research agency has discovered more than 3,000 new types of brain cells in different clusters.

Read More